B. F. Morley-r, Drug-induced cystitis: the need for vigilance, Review. British Journal of Urology, vol.79, pp.3-7, 1997.

C. B. Van, Cystitis due to the use of ketamine as a recreational drug: a case report

D. M. Nixon-p and C. J. Et, Drug-Induced Bladder and Urinary Disorders, Incidence, Prevention and Management, Drug Safety, pp.45-55, 1998.

G. M. Burnett-j, Medications and green urine. Letters to the Editor, Royal Australasian College of Physicians, pp.64-66, 2006.

H. M. Imamura-t, T. S. , and K. H. Mori-e, Urinary incontinence: an unrecognised adverse effect with donepezil. Research letters. The Lancet, p.568, 2000.

L. P. Loly-c, . Delanaye-p, and . Garweg-c, Green urine. Clinical Picture. The Lancet, p.1462, 2009.

L. L. Mueller-e, . Sharma-s, and F. M. Et, Urinary hesitancy and retention during treatment with sertraline

M. K. Blanchona-m.-a and L. A. , Impact sur les fonctions cognitives des anticholinergiques prescrits chez les patients âgés de plus de 65 ans pour hyperactivité vésicale, NPG Neurologie -Psychiatrie -Gériatrie, vol.8, pp.6-15, 2008.

M. C. , K. A. Le-boisselier-r, G. J. , and D. D. , Le syndrome de la poche à urine violette : à propos d'un cas avec identification des substances colorantes

M. Vary and K. T. , Non-steroidal anti-inflammatory drugs and urinary retention, www.thelancet.com Vol, vol.367, 2006.

M. H. Matsutani-r, M. A. Et, and N. , Case of acute urinary retention as a result of non-steroidal anti-inflammatory drugs, International Journal of Urology, vol.14, pp.368-369, 2007.

S. C. L-'incontinence-urinaire-chez-la-femme, Progrès en urologie, p.280, 2009.

T. O. Desgrandchamps-f, . Sebe-p, . Haab-f, . A. Le, . Gattegno-b et al., Cystite hémorragique : étiologie et traitement, Progrès en Urologie, vol.11, pp.591-601, 2001.

V. N. and S. S. Caputo-r, Serotonergic antidepressants and urinary incontinence

V. J. Md, F. , and C. , The Role of Geriatricians and Family Practitioners in the Treatment of Overactive Bladder and Incontinence, Reviews in Urology, vol.4, pp.44-49, 2002.

A. Cohen, M. , A. Ca, and M. M. , Development of urinary retention during treatment with clozapine and meclizine

B. G. Annales-de-dermatologie-et-de, C. M. , P. Af, K. T. , I. B. et al., -Morocco 35 Transient urinary incontinence after subarachnoid anesthesia with 0.5% heavy bupivacaine, Venereologie Anesthesia and Analgesia, vol.135, issue.103 4, pp.776-777, 2006.

C. Gl, M. R. Stenson-ma, and R. Dd, Venlafaxine and urinary incontinence: possible association, Annals of Pharmacotherapy, vol.31, p.372, 1997.

D. P. and S. Vk, Acute urinary retention associated with atomoxetine use, Australian and New Zealand Journal of Psychiatry, vol.40, issue.936 10, 2006.

D. Genova-e, D. , and A. G. , Permanent Urinary Incontinence After Subarachnoid Anesthesia with 0.5% Hyperbaric Bupivacaine, Anesthesia & Analgesia, vol.105, issue.5, pp.1517-1518, 2007.
DOI : 10.1213/01.ane.0000286132.49797.9d

F. A. , R. Km, O. D. , and S. Rt, Same patient, new stone composition: amprenavir urinary stone

G. F. , L. K. , R. Nm, and C. Gc, Postmenopausal hormone therapy and risk of developing urinary incontinence, Obstetrics and Gynecology, vol.103, issue.2, pp.254-260, 2004.

H. H. , B. Salem-c, G. M. , S. R. , and B. K. , Carbamazepineinduced urinary retention, British Journal of Clinical Pharmacology: Online first, 2007.

K. G. Hackett-rl and W. Z. , Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer, Urology, vol.47, pp.928-929, 1996.

K. A. Virk-s and M. Ps, Urinary incontinence with mirtazapine, Journal of Clinical Psychiatry, vol.63, p.454, 2002.

I. H. , V. Ma, D. M. , M. Ha, C. F. et al., Efavirenz urolithiasis, AIDS, vol.21, issue.14, 1992.

I. Document, L. L. , M. Er, S. S. , and F. Mp, Available from: URL: http://www.lareb.nl 53 Urinary hesitancy and retention during treatment with sertraline, 2005.

M. S. Brenner-r, Risperidone-induced ejaculatory and urinary dysfunction, Journal of Clinical Psychiatry, vol.57, pp.549-550, 1996.

M. R. , C. Lm, P. Nr, and C. K. , Urinary retention associated with ziprasidone: a case report, Journal of Clinical Psychiatry, vol.69, issue.3, pp.499-500, 2008.

M. Hj and B. Dg, Alpha-Adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility, British Journal of Clinical Pharmacology, vol.42, pp.507-509, 1996.

M. A. Hirota-k, . Satone-t, and . Ito-y, Pink urine during propofol anesthesia, Anesthesia and Analgesia, vol.83, pp.666-667, 1996.

M. Rhb, B. Cce, D. Wl, . Van-puijenbroek, and . Ep, Bladder dysfunction during the use of tramadol, Pharmacoepidemiology and Drug Safety, vol.8, pp.63-64, 1999.

M. Kll, L. Hgm, B. Sv, L. Aw, and E. Acg, Selective serotonin reuptake inhibitor-induced urinary incontinence, Pharmacoepidemiology and Drug Safety, vol.11, pp.271-279, 2002.

O. Jd, J. Ss, D. Ad, and J. H. , Urinary tract infections and estrogen use in older women, Journal of the American Geriatrics Society, vol.40, pp.817-820, 1992.

P. K. , P. Ta, B. M. , P. B. , and D. S. , Urinary incontinence with donepezil treatment in hospitalized children and adolescents with attention deficit hyperactivity disorder, Journal of Child and Adolescent Psychopharmacology, vol.13, issue.1, pp.111-112, 2003.

P. Perez-r, M. Pena-mj, C. Mj, and M. , Cyproheptadine-induced urinary obstruction

P. G. , S. F. , C. P. , N. G. , R. A. et al., Venlafaxine-induced urinary incontinence resolved after switching to sertraline, Clinical Neuropharmacology, vol.28, issue.5, pp.247-248, 2005.

R. Sp and M. A. , Urinary incontinence caused by prazosin

S. We, D. J. , J. F. , and D. J. , Dose-dependent urinary retention following olanzapine administration, Annals of PharmacotherapyCanada, vol.40, issue.9, p.1693, 2006.

S. M. , B. S. Onorato-l, Y. Rw, G. M. , and N. D. , Primary myositis coinciding with vincristine-induced neuropathic pain and urinary retention in rhabdomyosarcoma: an unusual occurrence Journal of Pediatric Hematology Eight days of cyclosporine overdose: a case report, -India 72. SKETRIS IS, pp.658-660, 1993.

S. Kn and M. M. Brown-bj, Urinary retention following repeated highdose quetiapine, Annals of Pharmacotherapy, vol.38, issue.5, pp.899-900, 2004.

T. M. , R. J. , V. C. Vazquez-m, A. J. Bermudez-m, and A. Pg, Two unusual cases of urinary incontinence during continuous sciatic nerve block with stimulating catheters, Anesthesia and Analgesia, vol.108, issue.3, pp.1042-1043, 2009.

T. , H. Ym, and W. Mm, Cyclophosphamideinduced cystitis and bladder cancer in patients with Wegener granulomatosis, Annals of Internal Medicine, vol.124, issue.1, pp.477-484, 1996.

T. Ck and L. C. Cheng-kc, Propofol-related green urine, Kidney International, vol.74, issue.978 7, 2008.

U. A. Torun-e, . Sipahioglu-mh, . Tokgoz-b, . Kaya-mg, . Oymak-o et al., Fenofibrate-induced acute renal failure due to massive rhabdomyolysis after coadministration of statin in two patients, Internal Medicine, vol.47, issue.11, pp.1017-1019

V. Kmc, D. Jp, . Van-wijk, . Mam, . J. Van-der-lei et al., Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention, Archives of Internal Medicine, vol.165, issue.13, pp.1547-1551, 2005.

V. Lt, F. Ma, H. H. , and V. Km, Olanzapine-induced urinary incontinence: treatment with ephedrine, Journal of Clinical Psychiatry, vol.61, pp.601-602, 2000.

W. Gj, T. J. , G. Jd, and I. Ce, Efavirenz-induced urolithiasis, Urological Research, vol.34, issue.4, pp.288-289, 2006.

X. D. , B. Vp, G. G. , N. N. , G. J. et al., Urinary hesitancy and retention caused by ziprasidone, International Clinical Psychopharmacology, vol.21, issue.1, pp.71-72, 2006.

H. Je, W. Ms, and V. Sr, Fluoxetine and the bleeding time, Arch Pathol Lab Med, vol.114, pp.727-735, 1990.

J. Ap, Urapidil and enuresis, Lancet, vol.339, p.688, 1992.

M. P. O-'brien-c, Extending levodopa action: COMT inhibition, Neurology, vol.50, pp.527-532, 1998.

G. Parkinson-study, Entacapone improves motor fluctuations in levodopa- treated Parkinson's disease patients, Annals of Neurology, vol.11, issue.5, pp.747-755, 1997.
DOI : 10.1002/ana.410420511

N. Préaux, Dossier du CNIMH 1991. XII, p.264

A. M. Antihistamines, H1-receptor antagonits) In : Dukes MNG and Aronson JK Meyler's side effects of drugs, pp.481-491, 2000.

B. L. Dukes, M. Aronson, and J. , Non-steroidal anti-inflammatory drugs

B. S. Et and O. , Antidepressant drugs In : Dukes MNG and Aronson JK Meyler's side effects of drugs, pp.33-85, 2000.

C. A. , N. K. Fux-c, and H. R. Penicillins, In: Dukes MNG and Aronson JK Meyler's side effects of drugs, pp.810-830, 2000.

M. Masso, J. , and L. Cundi-g, Drugs affecting autonomic functions or the extrapyramidal system

S. M. Dukes, M. Aronson, and J. , Antiprotozoal drugs

S. Go, P. Eh, S. Dukes, M. Aronson, and J. , Neuroleptic and antipsychotic drugs

. Martindale, The Extra Pharmacopoeia

. Martindale, The Extra Pharmacopoeia 31ème ed, p.985, 1996.

. Martindale, The Complete Drug Reference 32ème ed, p.242, 1999.

. Martindale, The Complete Drug Reference 32ème ed, p.372, 1999.

. Martindale, The Complete Drug Reference 32ème ed, p.1215, 1999.

. Martindale, The complete drug référence 32ème ed, p.1089, 1999.

. Martindale, The Complete Reference Drug 33ème ed, p.478, 2002.

. Martindale, The complete drug reference 33ème ed, p.552, 2002.

. Martindale, The complete drug reference, p.885, 2002.

. Martindale, The complete drug reference 34ème ed, p.292, 2005.

. Martindale, The complete drug reference 34ème ed, pp.292-296, 2005.

. Martindale, The complete drug reference 34ème ed, pp.475-491, 2005.

. Martindale, The complete drug reference 34ème ed, p.575, 2005.

. Martindale, The complete drug reference 34ème ed, pp.640-642, 2005.

. Martindale, The Complete Drug reference 34ème ed, pp.1205-1215, 2005.

. Martindale, The Complete Drug Reference 34ème ed, p.1456, 2005.

. Martindale, The Complete Drug Reference 34ème ed, pp.1527-1552, 2005.

. Martindale, The complete drug reference 35ème ed, pp.275-281, 2007.

. Martindale, The complete drug reference 35ème ed, pp.333-89, 2007.

. Martindale, The complete drug reference 35ème ed, pp.368-377, 2007.

. Martindale, The Complete Drug Reference-35ème ed, pp.383-387, 2007.

. Martindale, The Complete Reference Drug 35ème ed, p.578, 2007.

. Martindale, The complete drug reference 35ème ed, pp.851-937, 2007.

. Martindale, The complete drug reference 35ème ed, p.1008, 2007.

. Martindale, The complete drug reference 35ème ed, p.1031, 2007.

. Martindale, The complete drug reference 35ème ed, pp.1034-1277, 2007.

. Martindale, The complete drug reference 35ème ed, pp.1034-1290, 2007.

. Martindale, The complete drug reference 35ème ed, p.1274, 2007.

. Martindale, The complete drug reference 35ème ed, p.1276, 2007.

. Martindale, The complete drug reference 35ème ed, pp.1295-1298, 2007.

. Martindale, The complete drug reference 35ème ed, pp.1527-1602, 2007.

. Martindale, The complete drug reference 35ème ed, pp.1622-1659, 2007.

. Martindale, The Complete Drug Reference 35ème ed, p.1735, 2007.

. Martindale, The Complete Drug Reference 36ème ed, pp.2-133, 2009.

. Martindale, The complete drug reference 36ème ed, pp.158-361, 2009.

. Martindale, The Complete Drug Reference 36ème, pp.561-593, 2009.

. Martindale, The Complete Drug Reference 36ème ed, pp.1083-1107, 2009.

. Martindale, The complete drug reference 36ème ed, p.1206, 2009.

. Martindale, The complete drug reference 36ème ed, p.1439, 2009.

. Martindale, The complete Drug Reference 36 ème ed, pp.1983-1988, 2009.